Quinazoline-sulfonamides as potential antitumor agents: Synthesis and biological testing

8Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

New series of quinazoline containing sulfonamide derivatives were prepared and screened for their antitumor activity. Four human cancer cell lines, namely, hepatoma cancer cell line (HepG2), breast cancer cell line (MCF-7), cervix cancer cell line (HeLa) and colon cancer cell line (HCT-8), were used to measure the cytotoxic activity. Compounds 8 and 21 exhibited remarkable antitumor activity almost similar to that of the standard drug (doxorubicin). Six compounds 16, 22, 23, 29, 30 and 33, showed considerable activity and few compounds were totally inactive.

Cite

CITATION STYLE

APA

Alafeefy, A. M., Alqasoumi, S. I., Ashour, A. E., & Alshebly, M. M. (2013). Quinazoline-sulfonamides as potential antitumor agents: Synthesis and biological testing. Journal of Enzyme Inhibition and Medicinal Chemistry, 28(2), 375–383. https://doi.org/10.3109/14756366.2012.668541

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free